Australia
TINYBEANS ACQUIRES QEEPSAKE CREATING THE LEADING PRIVACY-FIRST FAMILY MEMORY PLATFORM
Tinybeans accelerates innovation in privacy-first, secure family memory-keeping SYDNEY, Nov. 3, 2025 /PRNewswire/ -- Tinybeans Group (ASX:TNY, OTCQB:TNYYF), the global privacy-first family photo-sharing and journaling app, today announced the acquisition of the assets of Qeepsake Inc., aBoston-ba...
Locksley Receives Up to US$191 Million Potential Support from EXIM for U.S. Critical Minerals Push
SAN BERNARDINO, Calif., Nov. 3, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF) announced the receipt of a Letter of Interest (LOI) from the Export-Import Bank ofthe United States (EXIM) outlining the intent to provide up toUS$191 million in potential project financing su...
The 2025 Conference on Wang Yangming Mind Philosophy opens in Yuyao, Ningbo
NINGBO, China, Oct. 30, 2025 /PRNewswire/ -- October 31 marks the birth
anniversary of the great Chinese philosopher Wang Yangming (1472-1529). On
October 30, the 2025 Conference on Wang Yangming Mind Philosophy was
inaugurated in Yuyao,Ningbo.
e-STORAGE Achieves Commercial Operation of 220 MWh Mannum Battery Energy Storage Project in South Australia
KITCHENER, ON, Oct. 29, 2025 /PRNewswire/ -- Canadian Solar Inc.
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
* Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies * Partnership with T cell experts Daniel J Powell Jr., PhD, and Mark Yarmarkov...
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner
SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) p...
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 * We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Kor...
Co-PSMA trial achieves primary endpoint
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT...
Locksley Announces Major Advancement at Mojave as Structural Mapping Expands Scale of Antimony Target with a 400% Increase in Target Strike Length
SAN BERNARDINO, Calif., Oct. 10, 2025 /PRNewswire/ -- Locksley Resources, Ltd. (ASX: LKY; OTCQX: LKYRYF) announced that recent structural mapping has significantly expanded the scale of its target mineralized corridor at the Desert Antimony Mine (DAM) Prospect. A new parallel structural target wa...
Locksley Reports High-Grade Antimony Concentrate at Significantly Higher Grades than Comparable American Projects in Initial Metallurgical Test Work of Surface Samples from the Company's Desert Antimony Mine Project in California
SAN BERNARDINO, Calif., Oct. 8, 2025 /PRNewswire/ -- Locksley Resources, (ASX: LKY; OTCQB: LKYRF) announced that the company's advancing metallurgical test work program being conducted on surface samples collected from the Desert Antimony Mine (DAM) Prospect at the company's project in the Mojave...
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...
FDA Lifts Clinical Hold on NUZ-001
Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...
ISX Financial EU Plc Reports Profitable Growth and Strong Capital Position in H1 2025
NICOSIA, Cyprus, Oct. 3, 2025 /PRNewswire/ -- ISX Financial EU Plc (ISXX), a leading provider of regulated transactional banking and real-time payment solutions, today announced its unaudited H1 2025 financial results for the six months ended30 June 2025. ISXX delivered profitable growth, improve...
EVOLVE MVMT Launches Wearable to Track Shock Absorption for Runners
Revolutionary running tech offers real-time insights into step quality, injury risk, and performance. BYRON BAY, Australia, Sept. 30, 2025 /PRNewswire/ -- EVOLVE MVMT has launched the world's first wearable designed specifically to measure shock absorption and step quality for runners on Kicksta...
Lumonus Announces Transformative Multi-Year Licensing Agreement with Smarter Radiation Oncology® to bring evidenced-based directives to U.S. cancer centers
NEW YORK and SYDNEY, Sept. 29, 2025 /PRNewswire/ -- Lumonus
Locksley Names Industry Veterans CEO and COO to Fast-Track its US Mine-to-Market Effort
SAN BERNARDINO, Calif., Sept. 25, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQB: LKYRF) announced the appointment ofKerrie Matthews as Chief Executive Officer (CEO) andDanny George as Chief Operating Officer (COO) of the company. The appointments are newly-created positions and...
Locksley Continues to Strengthen its Position in Paving Pathway to 100% Made in America
Company Reports Exceptional Initial Metallurgical Results for Its US Mojave Project SAN BERNARDINO, Calif, Sept. 22, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has achieved significant results from initial metallurgical testwork completed by the company on...
Aduna Welcomes Spark as First New Zealand Partner
PLANO, Texas, Sept. 17, 2025 /PRNewswire/ -- Aduna
/DISREGARD RELEASE: GIM Trading/
Journalists and other readers should disregard the news release, GIM Trading Unveils Commitment to Long-Term Investment Solutions Amid Shifts in Australian Economic Landscape, issued28-May-2024 over PR Newswire. ...
Week's Top Stories
Most Reposted
Futurise Impact Report 2025 Highlights Progress in Regulatory Innovation Future-Ready Technologies
[Picked up by 272 media titles]
2026-09-09 13:26Hyundai Motor Company Becomes Official Automotive Partner of the UEFA Champions League
[Picked up by 266 media titles]
2026-09-07 13:00People See One Brand. The Internet May Show Them Hundreds More.
[Picked up by 264 media titles]
2026-09-07 09:00Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
[Picked up by 264 media titles]
2026-09-10 15:00Nuix Expands Generative AI for Legal Review, Debuts AI Chat for Case Data
[Picked up by 262 media titles]
2026-09-07 09:40